Analyze Diet
Equine veterinary journal2026; doi: 10.1002/evj.70339

Predicting outcomes in equine peritonitis: Multivariable analysis of admission and post-admission data from a UK hospital population.

Abstract: Peritonitis is life-threatening, and limited information exists regarding outcomes and predictors of survival. Objective: To report short- and long-term outcomes in horses diagnosed with peritonitis and identify factors associated with survival. Methods: Retrospective observational. Methods: Data were obtained for horses admitted to a UK referral hospital between 2010 and 2024 diagnosed with peritonitis (peritoneal fluid nucleated cell count >10 × 10/L). Short- and long-term morbidity and mortality were assessed. Multivariable logistic regression was used to identify factors associated with short-term survival based on data available at admission (Model 1) and at the time of second abdominocentesis (Model 2). Results: Peritonitis was diagnosed in 123 horses. Overall, short-term survival was 74% (91/123) with better outcomes in primary (90%, 66/73) versus secondary peritonitis (50%, 25/50). Surgery was performed in 31 cases, with short-term survival of 48% (15/31). In model 1, horses with higher heart rates (OR 0.90, 95% CI 0.86-0.95, p < 0.001) and sanguinous peritoneal fluid (OR 0.16, 95% CI 0.04-0.65, p = 0.01) were significantly less likely to survive to hospital discharge. Survival was better in ponies vs. horses (OR 8.30, 95% CI 1.42-48.60, p = 0.02), and if rectal examination was normal (OR 8.25, 95% CI 1.80-37.85, p = 0.007). In Model 2, increased heart rate was the best predictor of reduced survival (OR 0.89, 95% CI 0.83-0.94, p < 0.001). Survival to 30, 90, and 365 days was 98% (n = 50/51), 93% (n = 42/45), and 88% (n = 35/40), respectively. A third of horses developed complications following hospital discharge (predominantly colic and pyrexia), usually within 90 days of hospital admission. Peritonitis recurred in 6 horses. Conclusions: Retrospective study from a single hospital population. Conclusions: The prognosis for primary peritonitis is better than secondary peritonitis. Heart rate is a good predictor of short-term survival at admission and time of repeat abdominocentesis.
Publication Date: 2026-09-30 PubMed ID: 42817205DOI: 10.1002/evj.70339Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study analyzed outcomes of horses with peritonitis admitted to a UK hospital to identify factors that predict survival.
  • The research found that heart rate and certain clinical signs were key predictors of short-term survival, with better outcomes for primary peritonitis compared to secondary peritonitis.

Background and Objective

  • Peritonitis is a severe and potentially fatal inflammation of the abdominal lining in horses.
  • There has been limited data on survival outcomes and predictors of survival in equine peritonitis cases.
  • The study aimed to report both short- and long-term survival and to identify clinical factors associated with outcomes in affected horses.

Methods

  • Retrospective observational study using data from horses diagnosed with peritonitis at a UK referral hospital from 2010 to 2024.
  • Diagnosis required a peritoneal fluid nucleated cell count over 10 × 10⁹/L.
  • Short- and long-term morbidity and mortality were collected and analyzed.
  • Multivariable logistic regression identified predictors of short-term survival using two models:
    • Model 1 used data available at admission.
    • Model 2 used data available at the time of a second abdominal fluid sample (abdominocentesis).

Results

  • 123 horses diagnosed with peritonitis were included in the analysis.
  • Overall short-term survival rate was 74% (91 out of 123 horses survived to hospital discharge).
  • Survival was substantially better in primary peritonitis cases (90%) compared to secondary peritonitis (50%).
  • 31 horses underwent surgery, with only 48% short-term survival post-operation.
  • Model 1 predictors of decreased survival at admission:
    • Higher heart rates (Odds Ratio (OR) 0.90): each increased beat per minute decreases survival odds.
    • Sanguineous (bloody) peritoneal fluid (OR 0.16) indicated worse prognosis.
  • Model 1 predictors of better survival:
    • Ponies had significantly better survival odds than horses (OR 8.30).
    • Normal rectal examination findings correlated with improved survival (OR 8.25).
  • Model 2 results (at second abdominocentesis) reaffirmed increased heart rate as the strongest predictor of poor survival (OR 0.89).
  • Long-term survival rates post-discharge were high:
    • 98% survival at 30 days.
    • 93% survival at 90 days.
    • 88% survival at 1 year (365 days).
  • About one-third of horses developed complications after hospital discharge, mainly colic and fever, typically within 90 days of admission.
  • Peritonitis recurrence was rare, occurring in 6 horses.

Conclusions and Clinical Implications

  • The prognosis for primary peritonitis is substantially better than for secondary peritonitis.
  • Heart rate is a reliable and easily measured clinical indicator for predicting short-term survival at both admission and after initial treatment.
  • Clinical findings such as rectal exam results and the nature of abdominal fluid also contribute important prognostic information.
  • Despite a life-threatening illness, most horses that survive to hospital discharge have favorable long-term outcomes.
  • Monitoring for complications is important within the first 3 months post-discharge to manage and mitigate risks effectively.
  • The findings can help veterinarians triage cases, inform owners, and guide treatment decisions in equine peritonitis management.
  • Limitations include the retrospective design and data from a single referral center, which may impact generalizability.

Cite This Article

APA
Kopec EK, Carslake H, Archer DC, Morris B, Wilson A. (2026). Predicting outcomes in equine peritonitis: Multivariable analysis of admission and post-admission data from a UK hospital population. Equine Vet J. https://doi.org/10.1002/evj.70339

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English

Researcher Affiliations

Kopec, E K
  • Philip Leverhulme Equine Hospital, University of Liverpool, Cheshire, UK.
Carslake, H
  • Philip Leverhulme Equine Hospital, University of Liverpool, Cheshire, UK.
Archer, D C
  • Philip Leverhulme Equine Hospital, University of Liverpool, Cheshire, UK.
Morris, B
  • Philip Leverhulme Equine Hospital, University of Liverpool, Cheshire, UK.
Wilson, A
  • Philip Leverhulme Equine Hospital, University of Liverpool, Cheshire, UK.

Grant Funding

  • University of Liverpool

References

This article includes 32 references
  1. Arndt S, Kilcoyne I, Vaughan B, Dechant JE. Clinical and diagnostic findings, treatment, and short‐ and long‐term survival in horses with peritonitis: 72 cases (2007–2017).. Vet Surg 2021;50(2):323–335.
  2. Davis JL. Treatment of peritonitis.. Vet Clin North Am Equine Pract 2003;19(3):765–778.
  3. Dyson S. Review of 30 cases of peritonitis in the horse.. Equine Vet J 1983;15(1):25–30.
  4. Peroni JF. Diagnosis and treatment of peritonitis and hemoperitoneum.. The equine acute abdomen. Hoboken, NJ: Wiley‐Blackwell; 2017. p. 361–375.
  5. Southwood LL, Russell G. The use of clinical findings in the identification of equine peritonitis cases that respond favorably to medical therapy.. J Vet Emerg Crit Care 2007;17(4):382–390.
  6. Gay CC, Lording PM. Peritonitis in horses associated with Actinobacillus equuli.. Aust Vet J 1980;56(6):296–300.
  7. Odelros E, Kendall A, Hedberg‐Alm Y, Pringle J. Idiopathic peritonitis in horses: a retrospective study of 130 cases in Sweden (2002–2017).. Acta Vet Scand 2019;61(1):18.
  8. Henderson ISF, Mair TS, Keen JA, Shaw DJ, McGorum BC. Study of the short‐ and long‐term outcomes of 65 horses with peritonitis.. Vet Rec 2008;163(10):293–297.
  9. Mair TS, Hillyer MH, Taylor FG. Peritonitis in adult horses: a review of 21 cases.. Vet Rec 1990;126(23):567–570.
  10. Matthews S, Dart A, Dowling B, Hodgson J, Hodgson D. Peritonitis associated with Actinobacillus equuli in horses: 51 cases.. Aust Vet J 2001;79(8):536–539.
  11. Hawkins JF, Bowman KF, Roberts MC, Cowen P. Peritonitis in horses: 67 cases (1985–1990).. J Am Vet Med Assoc 1993;203(2):284–288.
  12. Hedberg‐Alm Y, Tydén E, Tamminen L‐M, Lindström L, Anlén K, Svensson M. Clinical features and treatment response to differentiate idiopathic peritonitis from non‐strangulating intestinal infarction of the pelvic flexure associated with Strongylus vulgaris infection in the horse.. BMC Vet Res 2022;18(1):149.
  13. Golland LC, Hodgson DR, Hodgson JL, Brownlow MA, Hutchins DR, Rawlinson RJ. Peritonitis associated with Actinobacillus equuli in horses: 15 cases (1982–1992).. J Am Vet Med Assoc 1994;205(2):340–343.
  14. Nógrádi N, Tóth B, Macgillivray K. Peritonitis in horses: 55 cases (2004–2007).. Acta Vet Hung 2011;59(2):181–193.
  15. Brownlow MA, Hutchins DR, Johnston KG. Reference values for equine peritoneal fluid.. Equine Vet J 1981;13(2):127–130.
  16. Lawson AL, Mair TS, Fairburn A, Sherlock CE, Archer DC, Carslake HB. Evaluation of a protocol for a modified fast localised abdominal sonography of horses (FLASH) admitted for colic. Equine Vet J 2021;53(S55):6.
  17. Hillyer MH, Wright CJ. Peritonitis in the horse. Equine Vet Educ 1997;9(3):136–142.
  18. Corley K, Stephen J. In: Corley K, Stephen J, editors. The equine hospital manual. Oxford, UK: Blackwell Publishing; 2008.
  19. StataCorp. Stata stasticial software; Release 19. College Station, TX: StataCorp LLC; 2025.
  20. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 2007;147(8):573–577.
  21. Dahoo I, Martin W, Stryhm H. Logistic regression. 2009. p. 865–915.
  22. Isgren CM. Improving clinical outcomes via responsible antimicrobial use in horses. Equine Vet Educ 2022;34(9):482–492.
  23. Isgren CM, Williams NJ, Fletcher OD, Timofte D, Newton RJ, Maddox TW. Antimicrobial resistance in clinical bacterial isolates from horses in the UK. Equine Vet J 2022;54(2):390–414.
  24. van der Linden MA, Laffont CM, van Oldruitenborgh‐Oosterbaan MMS. Prognosis in equine medical and surgical colic. J Vet Intern Med 2003;17(3):343–348.
  25. Kos V, Kramaric P, Brložnik M. Packed cell volume and heart rate to predict medical and surgical cases and their short‐term survival in horses with gastrointestinal‐induced colic. Can Vet J 2022;63:365–372.
  26. Lundberg S. Peritonitis in horses—a retrospective study of 69 cases admitted to a university hospital during a ten year period. Uppsala: Swedish University of Agricultural sciences; 2014.
  27. Van Den Boom R, Butler CM, Sloet van Oldruitenborgh‐Oosterbaan MM. The usability of peritoneal lactate concentration as a prognostic marker in horses with severe colic admitted to a veterinary teaching hospital. Equine Vet Educ 2010;22(8):420–425.
  28. Kaufman JM, Nekouei O, Doyle AJ, Biermann NM. Clinical findings, diagnoses, and outcomes of horses presented for colic to a referral hospital in Atlantic Canada (2000–2015). Can Vet J 2020;61(3):281–288.
  29. Barton MH, Parviainen A, Norton N. Polymyxin B protects horses against induced endotoxaemia in vivo. Equine Vet J 2004;36(5):397–401.
  30. Morresey PR, MacKay RJ. Endotoxin‐neutralizing activity of polymyxin B in blood after IV administration in horses. Am J Vet Res 2006;67(4):642–647.
  31. Parviainen AK, Barton MH, Norton NN. Evaluation of polymyxin B in an ex vivo model of endotoxemia in horses. Am J Vet Res 2001;62(1):72–76.
  32. Werners A. Treatment of endotoxaemia and septicaemia in the equine patient. J Vet Pharmacol Ther 2017;40(1):1–15.

Citations

This article has been cited 0 times.